[P66] ポスターセッション 66　乳腺（メタ）

[P66-3] Safety and Efficacy of Eribulin in Patients with Locally Advanced or Metastatic Breast Cancer: A Phase IV Study in India

^○Vaibhav Choudhary¹, Satheesh C T², Chinmoy K Bose³, Shiv Rajan⁴, Prakash Ss⁵, Chirag Desai⁶, Xiao Lin⁷, Balaji Patil⁸, Sameer Chaudhari⁸, Sudeep Gupta⁹ (1.HCG NCHRI Cancer Centre, Nagpur, India, 2.Global HealthCare Enterprises Ltd, Bangalore, 3.Netaji Subhash Chandra Bose Cancer Institute, Kolkata, 4.King George's Medical University, Lucknow, 5.KR Hospital Mysore Medical College& Research Institute, Mysore, 6.Hemato-Oncology Clinic, Vedanta Institute of Medical Sciences, Ahmedabad, 7.Eisai Co. Ltd, Japan, 8.Eisai Pharmaceuticals India Pvt. Ltd, India, 9.Tata Memorial Hospital, Mumbai)